China NT Pharma Group Company Limited announced that as disclosed in the Announcement, given the reasons as set out in the section headed "Publication of Annual Results" of the Announcement, there will be a delay in the publication of the audited annual results of the Group for the year ended 31 December 2021 (the "2021 Audited Results"). Based on the information currently available to the Company, the Company estimates that the 2021 Audited Results will be published on or before 16 May 2022. The Company will make further announcement(s) to inform its shareholders and potential investors on the expected date of publication as and when appropriate.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.023 HKD | -11.54% | -8.00% | -58.18% |
28/03 | China NT Pharma Group Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
15/01 | China NT Pharma Group Company Limited Announces Directorate Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-58.18% | 8.79M | |
+20.78% | 43.27B | |
+25.28% | 22.92B | |
+19.07% | 15.43B | |
+13.05% | 12.95B | |
+43.98% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- 1011 Stock
- News China NT Pharma Group Company Limited
- China NT Pharma Group Company Limited Updates on Delay in Publication of Audited Annual Results for the Year Ended 31 December 2021